Novartis was not in breach of code for “inventing” disease

BMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7385.396 (Published 15 February 2003) Cite this as: BMJ 2003;326:396
  1. Heather Simmonds, director
  1. Prescription Medicines Code of Practice Authority, London SW1YA 2DY

    EDITOR—Ferriman's news item is incorrect on at least two counts.1

    Firstly, it is not true to state that the authority had imposed no penalty on the company for issuing misleading literature. Novartis, like all companies ruled in breach of the Association of the British Pharmaceutical Industry's code of practice …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription